Is IgG galactosylation the relevant factor for pregnancy-induced remission of rheumatoid arthritis?
During pregnancy, most patients with rheumatoid arthritis (RA) experience spontaneous improvement of their disease activity. Among the soluble candidates that have been investigated in search for the most relevant disease-remitting factor are the galactosylation levels of immunoglobulin G (IgG). In RA, a higher percentage of IgG lacking the terminal galactose residues, thought to play a pro-inflammatory role, is found. During pregnancy, however, IgG galactosylation levels increase and correlate with improved disease activity. The question remains whether the increase in IgG galactosylation during pregnancy is a mere epiphenomenon or a true remission-inducing factor.
Frauke
F
Förger
Monika
M
Ostensen
D001172:Arthritis, Rheumatoid / Q000276:immunology* / Q000378:metabolism; D005260:Female; D005690:Galactose / Q000378:metabolism; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism*; D011247:Pregnancy / Q000276:immunology*; D011248:Pregnancy Complications / Q000276:immunology* / Q000378:metabolism; D012075:Remission, Spontaneous
D007074:Immunoglobulin G; D005690:Galactose